Dofetilide
Tikosyn
Antiarrhythmic
NADAC/unit
$0.1818
No Shortage
Tier 1: 60.2%
8 Manufacturers
24 ANDAs
Dofetilide stabilizes heart rhythm in patients with irregular heartbeat.
vs. brand Tikosyn: Generic saves up to 98% per unit
Market Intelligence
2023-08-16 Class III Recall: SUN PHARMACEUTICAL INDUSTRIES INC
2023-03-08 Class II Recall: Accord Healthcare, Inc.
2023-03-08 Class II Recall: Accord Healthcare, Inc.
2023-03-08 Class II Recall: Accord Healthcare, Inc.
Generic Manufacturers
ACCORD HEALTHCARE INCAUROBINDO PHARMA LTDBIONPHARMA INCDR REDDYS LABORATORIES SAGRANULES PHARMACEUTICALS INCMSN LABORATORIES PRIVATE LTDPFIZER PHARMACEUTICALS PRODUCTION CORP LTDSIGMAPHARM LABORATORIES LLCSUN PHARMACEUTICAL INDUSTRIES LTD
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.